选择性颈清扫与辅助放疗对N0高级别黏液表皮样癌生存的影响
该回顾性队列研究基于SEER数据库纳入2004至2018年310例N0高级别黏液表皮样癌患者,评估选择性颈清扫(END)与辅助放疗对生存的影响。T3-T4患者行END较未行者5年疾病特异性生存(74.3% vs 34.0%,P < .01)和总生存(55.2% vs 20.5%,P < .01)显著改善;在颈清扫后病理N0患者中辅助放疗对生存无影响。
要点
- T3-T4高级别黏液表皮样癌行END较未行者5年DSS和OS显著改善。
- 颈清扫后病理N0患者中,辅助放疗对DSS和OS均无显著影响。
- 多因素Cox回归控制混杂后END的生存获益仍然存在。
核心结论
- T3-T4高级别黏液表皮样癌行END且病理淋巴结阴性(pN0)者,5年DSS和5年OS较临床N0未行END者显著改善。
- 尽管68%患者接受辅助放疗,在pN0高级别黏液表皮样癌中未显示该治疗对结局有获益。
研究设计与样本
- 回顾性队列研究,数据来自美国国立癌症研究所SEER数据库。
- 纳入2004至2018年诊断为高级别黏液表皮样癌且淋巴结阴性(N0)的全部患者,共310例。
主要发现
- 腮腺为最常见原发部位(266例,86%)。
- 133例(42.9%)为T3-T4肿瘤,212例(68%)接受辅助放疗,223例(71.9%)行END。
- T3-T4高级别黏液表皮样癌行END较未行者5年DSS为74.3% vs 34.0%(P < .01),5年OS为55.2% vs 20.5%(P < .01)。
- 接受颈清扫且病理N0的患者中,辅助放疗对DSS无影响(84.0% vs 72.1%,P = .45),对OS无影响(52.1% vs 55.8%,P = .91)。
- 使用多因素Cox比例回归控制混杂因素后,END的生存获益仍然存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aim to evaluate the role of elective neck dissection (END) and adjuvant radiation on survival in N0 high-grade mucoepidermoid carcinoma (MEC). STUDY DESIGN: Retrospective cohort study. SETTING: National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database. METHODS: All patients diagnosed with high-grade MEC with node-negative disease (N0) from 2004 to 2018 were included. Demographic, clinicopathologic, treatment, and outcomes were analyzed. Kaplan-Meier survival curves were used to evaluate 5-year disease-specific survival (DSS) and 5-year overall survival (OS). Multivariate Cox regression analysis was used to control for confounders. RESULTS: A total of 310 patients with high-grade MEC and N0 (clinical and pathologic) disease were identified. The parotid was the most common primary site (266, 86%). Of included patients, 133 (42.9%) were T3-T4 tumors and 212 (68%) received adjuvant radiation. END was performed on 223 (71.9%) of cases. END in T3-T4 high-grade MEC led to significant improvements in DSS (74.3% vs 34.0%, P < .01) and OS (55.2% vs 20.5%, P < .01) as compared to no END. Subanalysis shows that in patients who received neck dissections and were pathologic N0, adjuvant radiation had no impact on DSS (84.0% vs 72.1%, P = .45) and OS (52.1% vs 55.8%, P = .91). Benefits persisted when controlling for confounders using multivariate Cox proportional regression. CONCLUSION: Patients with T3-T4 high-grade MEC who underwent END and found to be pathologically node-negative (pN0) had significantly improved 5-year DSS and 5-year OS than patients who were cN0 and did not undergo END. Importantly, although 68% of patients received adjuvant radiation, we show no benefit of this treatment modality on outcomes in pN0 high-grade MEC.
引用
- Panara K, Sangal N, Lakshmipathy D, et al. Survival Impact of Elective Neck Dissection and Adjuvant Radiation in N0 High-Grade Mucoepidermoid Carcinoma. Otolaryngol Head Neck Surg. 2024. PMID: 38426623. doi:10.1002/ohn.695
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。